Biotech SF
San Francisco Bay Area biotech stories.
Showing posts with label
Velomedix
.
Show all posts
Showing posts with label
Velomedix
.
Show all posts
Wednesday, February 8, 2012
Velmedix gets $10.2M in Series B funds, adds CEO and VP
Velomedix said it has closed $10.2 million in Series B funding.
In addition, the Menlo Park-based development stage medical device company named Jeff Gold as CEO and Michael Moore and vice president of operations.
Older Posts
Home
Subscribe to:
Posts (Atom)